Gland Pharma Limited (BOM:543245)

India flag India · Delayed Price · Currency is INR
1,721.65
+13.25 (0.78%)
At close: Jun 20, 2025
-5.75%
Market Cap 283.94B
Revenue (ttm) 56.17B
Net Income (ttm) 6.99B
Shares Out n/a
EPS (ttm) 42.40
PE Ratio 40.65
Forward PE 30.20
Dividend 18.00 (1.05%)
Ex-Dividend Date Aug 14, 2025
Volume 11,731
Average Volume 6,676
Open 1,686.50
Previous Close 1,708.40
Day's Range 1,686.50 - 1,758.40
52-Week Range 1,200.00 - 2,220.95
Beta n/a
RSI 67.46
Earnings Date Aug 1, 2025

About Gland Pharma

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood ... [Read more]

Industry Pharmaceutical Preparations
Founded 1978
Employees 4,286
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543245
Full Company Profile

Financial Performance

In 2024, Gland Pharma's revenue was 56.17 billion, a decrease of -0.85% compared to the previous year's 56.65 billion. Earnings were 6.99 billion, a decrease of -9.57%.

Financial Statements

News

There is no news available yet.